Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults. (Q40571190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Kok-Yong Seng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Kim-Hor Hee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gaik-Hong Soon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Nicholas Chew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lawrence Soon-U Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

4 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

Journal of Antimicrobial Chemotherapy

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

3298-3306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

Absorption of rifampin from various preparations and pharmaceutic forms

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Study of the effect of concomitant food on the bioavailability of rifampicin, isoniazid and pyrazinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Population pharmacokinetics of rifampicin in Mexican patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study G

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Pharmacokinetic Modeling of Plasma and Intracellular Concentrations of Raltegravir in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Mechanism-based concepts of size and maturity in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Diagnosing model diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV268

21 January 2018

Identifiers

DOI

10.1093/JAC/DKV268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342028%20AND%20SRC:MED&resulttype=core&format=json